Neoadjuvant Chemotherapy and Radiation Therapy for Newly Diagnosed Primary Intracranial Non-Germinoma Germ Cell Tumors (NGGCT), with Dose-Intensified Chemotherapy and Peripheral Blood Stem Cell Support for Refractory Disease